Berdel, Andrew F., Christoph Röllig, Clara Burkhard-Meier, Marco Tembrink, Julia M. Unglaub, Tim Sauer, Martina Crysandt, Edgar Jost, Paul Jaeger, Christoph Kiefel, Lars Fransecky, Krischan Braitsch, Katharina Götze, Kai Wille, Kerstin Schäfer-Eckart, Klaus Metzeler, Sara Hilber, Julian Ronnacker, Marcel Kemper, Nardos Hölscher, Klaus Wethmar, Thomas Schroeder, Sylvia Herold, David Poitz, Björn Steffen, Andreas Rank, Mathias Hänel, Jan Moritz Middeke, Martin Kaufmann, Andreas Burchert, Johannes Schetelig, Uwe Platzbecker, Christian Thiede, Matthias Stelljes, Georg Lenz, Hubert Serve, Claudia Baldus, Martin Bornhäuser, Carsten Müller-Tidow, Jan-Henrik Mikesch, Lukas Frenzel, Maher Hanoun, Leo Ruhnke, and Christoph Schliemann. 2020. “Venetoclax Combined With High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia: Outcomes and Risk Stratification”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2026.301102.